| Carol M Vaughan, MD | |
|
84 Marginal Way, Suite 900, Portland, ME 04101-2443 | |
| (207) 874-2445 | |
| (207) 523-8598 |
| Full Name | Carol M Vaughan |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 84 Marginal Way, Portland, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043289705 | NPI | - | NPPES |
| 2229081 | Other | AETNA | |
| 318650099 | Medicaid | ME | |
| 037999 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 015453 (Maine) | Primary |
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
On World No Tobacco Day, new figures show that adults in the East Midlands don't trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.
Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
On World No Tobacco Day, new figures show that adults in the East Midlands don't trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.
Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carol M Vaughan, MD 100 Foden Rd West, Suite 203, South Portland, ME 04106-2327 Ph: (207) 828-0361 | Carol M Vaughan, MD 84 Marginal Way, Suite 900, Portland, ME 04101-2443 Ph: (207) 874-2445 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
On World No Tobacco Day, new figures show that adults in the East Midlands don't trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.
Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.
› Verified 6 days ago
Toby M Fitzgerald, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 887 Congress St Ste 200, Portland, ME 04102 Phone: 207-771-5549 Fax: 207-771-7834 | |
Dr. Edward Bumno Yoon, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 895 Washington Ave, Portland, ME 04103 Phone: 207-791-3888 | |
Dr. Kathryn G Wadland, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 195 Fore River Pkwy, Suite 440, Portland, ME 04102 Phone: 207-553-6920 Fax: 207-553-6940 | |
Anne Marie Van Hengel, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 84 Marginal Way, Suite 900, Portland, ME 04101 Phone: 207-874-2445 Fax: 207-523-8598 | |
Dr. Debra K Sepulveda, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 Fax: 207-662-6219 | |
Mary Anne Carroll, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Maine Medical Center, 22 Bramhall Street, Portland, ME 04102 Phone: 207-662-0111 |